Influence of elastin-derived peptides on metalloprotease production in endothelial cells

Experimental and Therapeutic Medicine

Volumn 1, Issue 6, 2010, Pages 1057-1060

  Siemianowicz, Krzysztof ^a   Gminski, Jan ^a   Goss, Malgorzata ^a   Francuz, Tomasz ^a   Likus, Wirginia ^a   Jurczak, Teresa ^a   Garczorz, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Elastin derived peptides; Endothelium; Metalloproteases

Indexed keywords

ELASTIN; GELATINASE A; INTERSTITIAL COLLAGENASE; PEPTIDE DERIVATIVE;

AORTA; ARTERY ENDOTHELIUM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME ANALYSIS; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; ILIAC ARTERY;

EID: 78049274881     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.157     Document Type: Article

References (27)

1. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function and biochemistry. circ res 92: 827-839, 2003.
2. Nagase H and Woessner JF: Matrix metalloproteases. J Biol chem 274: 21491-21494, 1999.
3. Ross R: Atherosclerosis - an inflammatory disease. N Engl J med 340: 115-126, 1999.
4. Palombo D, Maione M, Cifiello BI, Udini M, Maggio D and Lupo M: Matrix metalloproteinases. their role in degenerative chronic diseases of abdominal aorta. J cardiovasc Surg 40: 257-260, 1999.
5. Pearce WH and Shively VP: Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs. Ann NY Acad Sci 1085: 117-132, 2006.
6. Nishimura K, Ikebuchi M, Kanaoka Y, Ohgi S, Ueta E, Nanba E and Ito H: Relationships between matrix metalloproteinases and tissue inhibitors of metalloproteinases in the wall of abdominal aortic aneurysms. int angiol 22: 229-238, 2006.
7. Ishii T and Asuwa N: Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloprotei- nases in aortic dissection. Hum pathol 31: 640-646, 2000.
8. Annabi B, Shedid D, Ghosm P, Kenigsberg RL, Desrosiers RR, Bojanowski MW, Beaulieu E, Nassif E, Moumdjian R and Béliveau R: Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 35: 539-546, 2002.
9. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC and Stone NJ; For the coordinating committee of the national cholesterol Education program: implications of recent clinical trials for the national cholesterol Education program adult treatment panel iii Guidelines. J am coll cardiol 44: 720-732, 2004.
10. Hornebeck W and Robert L: Elastase-like enzymes in aortas and human breast carcinomas: quantitative variations with age and pathology. adv Exp med Biol 79: 145-156, 1977.
11. Gminski J and Drozdz M: Succinyl trialanine p-nitroanilide hydrolytic activities in plasma and the aorta of rabbits experi- mentally immunized with soluble elastin. Exp pathol 43: 37-40, 1991.
12. Faury G, Ristori MT, Verdetti J, Jacob MP and Robert L: Effect of elastin peptides on vascular tone. J Vasc res 32: 112-119, 1995
13. Faury G, Garnier S, Weiss AS, wallach J, Fülöp T JR, Jacob MP, Mecham RP, Robert L and Verdetti J: Action of tropoelastin and synthetic elastin sequences on vascular tone and on free ca2+ level in human vascular endothelial cells. circ res 82: 328-336, 1998.
14. Robert L, Labat-robert J and Robert AM: Genetic, epigenetic and posttranslational mechanisms of aging. Biogerontology 11: 387-399, 2010.
15. Jackson CJ and Nguyen M: Human microvascular endothelial cells differ from macrovascular endothelial cells in their expres- sion of matrix metalloproteinases. int J Biochem cell Biol 29: 1167-1177, 1997.
16. Basu P, Sen U, Tyagi N and Tyagi SC: Blood flow interplays with elastin: collagen and mmp: timp ratios to maintain healthy vascular structure and function. Vasc health risk manag 6: 215-228, 2010.
17. Burridge KA and Friedman MH: Environment and vascular bed origin influence differences in endothelial transcriptional profiles of coronary and iliac arteries. Am J Physiol Heart Circ physiol 299: h837-h846, 2010.
18. Aboyans V, lacroix P and Criqui MH: Large and small vessel atherosclerosis: similarities and differences. prog cardiovasc dis 50: 112-125, 2007.
19. Galis ZS, Sukhova GK, Lark MW and Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of of human atherosclerotic plaques. J clin invest 94: 2493-2503, 1994.
20. Feldman LJ, Mazighi M, Scheuble A, Deux JF, De Benedetti E, Badier-comander C, Brambilla E, Henin D, Steg PG and Jacob MP: Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercho- lesterolemic rabbit. circulation 103: 3117-3122, 2001.
21. Tummers AM, Mountain DJ, Mix JW, Kirkpatric SS, Cassada DC, Stevens, SL, Freeman MB, Goldman MH and Grandas OH: Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia. J Surg res 160: 9-13, 2010.
22. Yasmin, McEniery CM, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR and Wilkinson IB: Matrix metalloproteinase-9 (mmp-9), mmp-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. arterioscler thromb Vasc Biol 25: 372, 2005.
23. Friese RS, Rao F, Khandrika S, Thomas B, Zielgler MG, Schmid-Schönbein GW and O'connor DT: Matrix metal- loproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. clin Exp hypertens 31: 521-533, 2009.
24. Qin X, Corriere MA, Matrisian LM and Guzman RJ: Matrix metalloproteinase inhibition attenuates aortic calcification. arterioscler thromb Vasc Biol 26: 1510-1516, 2006.
25. Kieffer P, Giummelly P, Schjoth B, Carteaux JP, Villemot JP, Hornebeck W and Atkinson J: Activation of metalloproteinase-2, loss of matrix scleroprotein content and coronary artery calcifi- cation. atherosclerosis 157: 251-254, 2001.
26. Pauly RR, Passaniti A, Bilato C, et al: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type iV collagenase activity and is inhibited by cellular differentiation. circ res 75: 41-54, 1994.
27. Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A and Eckstein HH: Inflammatory infiltrates and neovessels are relevant sources of mmps in abdominal aortic aneurysm wall. pathobiology 76: 243-252, 2009.